Bibliografias temáticas / Advanced therapy medicine

Literatura científica selecionada sobre o tema "Advanced therapy medicine"

Autor: Grafiati
Publicado: 20 de julho de 2024

Crie uma referência precisa em APA, MLA, Chicago, Harvard, e outros estilos

Selecione um tipo de fonte:

Índice

Consulte a lista de atuais artigos, livros, teses, anais de congressos e outras fontes científicas relevantes para o tema "Advanced therapy medicine".

Ao lado de cada fonte na lista de referências, há um botão "Adicionar à bibliografia". Clique e geraremos automaticamente a citação bibliográfica do trabalho escolhido no estilo de citação de que você precisa: APA, MLA, Harvard, Chicago, Vancouver, etc.

Você também pode baixar o texto completo da publicação científica em formato .pdf e ler o resumo do trabalho online se estiver presente nos metadados.

Artigos de revistas sobre o assunto "Advanced therapy medicine"

1

Mayr, Nina A., Simon S. Lo, Murat Alp Oztek, Charles G. Colip e William T. C. Yuh. "Advanced Neuroimaging for Advanced Radiation Therapy". Topics in Magnetic Resonance Imaging 28, n.º 2 (abril de 2019): 35–36. http://dx.doi.org/10.1097/rmr.0000000000000200.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
2

Zhao, Kai, Ying Na e Hui-Min Xu. "Advances in translational therapy for locally advanced gastric cancer". World Journal of Clinical Cases 11, n.º 11 (16 de abril de 2023): 2405–11. http://dx.doi.org/10.12998/wjcc.v11.i11.2405.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
3

Coleman III, W. P. "Advanced Dermatologic Therapy II". JAMA: The Journal of the American Medical Association 287, n.º 5 (6 de fevereiro de 2002): 646. http://dx.doi.org/10.1001/jama.287.5.646.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
4

Hanna, E., C. Marre e M. Toumi. "PHP348 - REGENERATIVE MEDICINE ADVANCED THERAPY: A BUDGET IMPACT ANALYSIS". Value in Health 21 (outubro de 2018): S209—S210. http://dx.doi.org/10.1016/j.jval.2018.09.1242.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
5

Gourbat, J. P. "Compression Therapy in Aeronautic Medicine". Phlebology: The Journal of Venous Disease 15, n.º 3-4 (dezembro de 2000): 178–81. http://dx.doi.org/10.1177/026835550001500319.

Texto completo da fonte
Resumo:
Aim: To review the influences of air and space travel on the venous side of the circulation and to assess the consequences for air and space travellers. Method: A review of current literature in the field of aeronautical travel has been conducted, with particular reference to the effects on the venous system and use of compression garments. Synthesis: The venous system is particularly sensitive to gravitational and pressure changes encountered during air and space travel due to the low pressures normally present in this part of the circulation. The symptoms experienced by air crew may be countered by the use of venous compression stockings, amongst other measures. More sophisticated techniques are required for fighter aviation and space flights. Aircraft and spacecraft travel in a hostile environment in which it is not possible for man to survive without sophisticated layers of protection. In addition, forces of acceleration generated by aircraft flight combine with those of the environment hazarding the safety and the health of navigators. Continuing technical advances allow increased performance towards ever greater speed, better acceleration, a greater range of action and longer periods of time in space. Conclusion: Increasingly, the limiting factor in air and space travel appears to be man, who has difficulty in tolerating the environment to which he is exposed. The immediate risk is loss of consciousness and in time there is the risk of health deterioration. The cardiovascular system as a whole is at the centre of this problem and seems to be one of the limiting factors in the design of more advanced aircraft, especially those used for military purposes.
Estilos ABNT, Harvard, Vancouver, APA, etc.
6

Mie, Takafumi, Takashi Sasaki, Takeshi Okamoto, Takaaki Furukawa, Tsuyoshi Takeda, Akiyoshi Kasuga, Masato Ozaka e Naoki Sasahira. "Current Status of Targeted Therapy for Biliary Tract Cancer in the Era of Precision Medicine". Cancers 16, n.º 5 (22 de fevereiro de 2024): 879. http://dx.doi.org/10.3390/cancers16050879.

Texto completo da fonte
Resumo:
First-line chemotherapy has been established for advanced biliary tract cancer (BTC). However, few treatment options are available as second-line treatment. Advances in comprehensive genomic analysis revealed that nearly half of patients with BTC harbor targetable genetic alterations such as fibroblast growth factor receptor (FGFR), isocitrate dehydrogenase (IDH), BRAF, human epidermal growth factor receptor 2 (HER2), microsatellite instability (MSI)-high, neurotrophic tropomyosin receptor kinase (NTRK), rearranged during transfection (RET), and poly (adenosine diphosphate-ribose) polymerase (PARP). This review summarizes currently available options in precision medicine and clinical trials for patients with advanced BTC.
Estilos ABNT, Harvard, Vancouver, APA, etc.
7

Del Portillo, Isabel, Christine Sesanto, Magdalena Parys e Juan Carlos Serra. "Radiation therapy in veterinary medicine: a practical review". Companion Animal 25, n.º 7 (2 de agosto de 2020): 1–15. http://dx.doi.org/10.12968/coan.2019.0056.

Texto completo da fonte
Resumo:
Radiotherapy is a treatment modality based on the use of high-energy rays to kill neoplastic cells, which has become an integral therapeutic tool in veterinary medicine. Radiotherapy may be an effective treatment for tumours that are not easily managed with surgery or with chemotherapy, even for patients with advanced-stage neoplasia. Novel uses of radiotherapy include rescue therapy for specific benign conditions that are refractory to conventional therapy. Acute and late toxicities depend on the prescribed protocol as well as sensitivity and volume of the normal tissue in or near the radiation field. The potential risks associated with the treatment should be fully discussed with owners before starting radiotherapy. New hardware and software technology has drastically advanced the ability to precisely target tumours, improving treatment efficacy and safety.
Estilos ABNT, Harvard, Vancouver, APA, etc.
8

Sai, Duc Loc, Jieun Lee, Duc Long Nguyen e Young-Pil Kim. "Tailoring photosensitive ROS for advanced photodynamic therapy". Experimental & Molecular Medicine 53, n.º 4 (abril de 2021): 495–504. http://dx.doi.org/10.1038/s12276-021-00599-7.

Texto completo da fonte
Resumo:
AbstractPhotodynamic therapy (PDT) has been considered a noninvasive and cost-effective modality for tumor treatment. However, the complexity of tumor microenvironments poses challenges to the implementation of traditional PDT. Here, we review recent advances in PDT to resolve the current problems. Major breakthroughs in PDTs are enabling significant progress in molecular medicine and are interconnected with innovative strategies based on smart bio/nanomaterials or therapeutic insights. We focus on newly developed PDT strategies designed by tailoring photosensitive reactive oxygen species generation, which include the use of proteinaceous photosensitizers, self-illumination, or oxygen-independent approaches. While these updated PDT platforms are expected to enable major advances in cancer treatment, addressing future challenges related to biosafety and target specificity is discussed throughout as a necessary goal to expand the usefulness of PDT.
Estilos ABNT, Harvard, Vancouver, APA, etc.
9

Goula, Aspasia, Vasiliki Gkioka, Efstathios Michalopoulos, Michalis Katsimpoulas, Michel Noutsias, Eirini Faidra Sarri, Catherine Stavropoulos e Alkiviadis Kostakis. "Advanced Therapy Medicinal Products Challenges and Perspectives in Regenerative Medicine". Journal of Clinical Medicine Research 12, n.º 12 (2020): 780–86. http://dx.doi.org/10.14740/jocmr3964.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
10

Vaggelas, Annegret, e Diane Seimetz. "Expediting Drug Development: FDA’s New Regenerative Medicine Advanced Therapy Designation". Therapeutic Innovation & Regulatory Science 53, n.º 3 (maio de 2019): 364–73. http://dx.doi.org/10.1177/2168479018779373.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
Mais fontes

Teses / dissertações sobre o assunto "Advanced therapy medicine"

1

VIGANI, BARBARA. "Development of Advanced Therapy Medicinal Products for Regenerative Medicine". Doctoral thesis, Università degli studi di Pavia, 2017. http://hdl.handle.net/11571/1203351.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
2

Coward, Jermaine. "The effects of anti-IL-6 therapy in advanced ovarian cancer". Thesis, Queen Mary, University of London, 2010. http://qmro.qmul.ac.uk/xmlui/handle/123456789/457.

Texto completo da fonte
Resumo:
IL-6 is a pleiotropic cytokine that has a significant role in inflammatory processes. In relation to ovarian cancer biology there is emerging evidence that it mediates processes relating to tumour growth, invasion, angiogenesis and chemo-resistance that lead to disease with poor prognosis. The aim of this thesis was to evaluate the efficacy and mechanism of action of an anti-human IL-6 antibody, CNTO328, in ovarian cancer. These aims were achieved with a clinical trial that was conducted in parallel with pre-clinical experiments. 18 patients with advanced platinum-resistant ovarian cancer were treated with CNTO328 in a phase II clinical trial. One patient had a partial response and seven patients attained stable disease at the end of the initial 6-week study period with correlations seen between clinical benefit and baseline levels of CRP, β2- microglobulin, TNF-α, IL-8 and VEGF. Four patients completed 6 months of treatment and had significantly decreased plasma CCL2 and increased sgp130 concentrations. Furthermore, immunohistochemical analysis of diagnostic biopsies suggested that clinical benefit was related to a lower macrophage infiltrate and increased stromal expression of IL-6, IL-6 receptors and SOCS3. I have found two ovarian cancer cell lines that secreted IL-6 and expressed both components of the IL-6 receptor signalling complex. When these cells were grown on plastic, CNTO328 had no effect on cell proliferation or survival. This suggested that IL-6 was not a growth factor for ovarian cancer cells in vitro. However, CNTO328 reduced constitutive secretion of IL-6, IL-1β, TNF-α, IL-8 and CCL2 by the ovarian cancer cells. The in vivo studies with human ovarian cancer xenograft models in nude mice showed that anti-IL-6 treatment had biological activity by inhibiting cell proliferation, macrophage infiltration and angiogenesis. In conclusion, the xenograft models and cell line experiments together with the clinical trial show that IL-6 may be a therapeutic target in ovarian cancer and exhibits both autocrine and paracrine actions within the ovarian cancer microenvironment.
Estilos ABNT, Harvard, Vancouver, APA, etc.
3

Fall, Per-Arne. "Aspects of Parkinson's disease. Epidemiology, risk factors and ECT in advanced disease". Doctoral thesis, Linköpings universitet, Geriatrik, 1999. http://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-5011.

Texto completo da fonte
Resumo:
The purpose was to investigate some aspects of epidemiology, risk factors and treatment with ECT in advanced Parkinson’s disease (PD). In study I, we performed a descriptive epidemiologic population-based survey in the Central Health Care District in Östergötland in south-east Sweden, with a population of almost 150,000 inhabitants 1989. The case finding was accomplished in three ways: 1. Collection of all prescriptions for Parkinson’s disease. 2. Search in medical files. 3. Checking with all nursing homes in the area. The crude prevalence was found to be 115 per 100,000 inhabitants. When we used the European Standard Population as a tool for easy comparisons of PD prevalence between different areas and time periods 76 PD-cases per 100,000 inhabitants were found. The corresponding incidences were 11.0 (crude) and 7.9 (age standardised) per 100,000 person-years. Mean age at onset was 65.6. A low prevalence and a high age at onset suggested that e.g. environmental factors could influence the occurrence of PD, and the results implies that only few such factors were present in the investigated area. The findings led to study II, a case-control study which investigated the possible impact of nutritional and environmental risk factors for idiopathic Parkinson’s disease (IP), including 113 cases and 263 control subjects. Dietary, drinking, and smoking habits, as well as previous occupation, were requested in a structured questionnaire. No increased risk was found for any of the nutrients. A reduced risk was found for coffee, wine, and spirits but also for broiled meat, smoked ham or meat, eggs, French loaf or white bread, and tomatoes. These findings could indicate an antioxidant effect. Frequency of preceding and present smoking was reduced in IP patients. Possible mechanisms are discussed. Various occupational groups and exposures were analysed and increased risks of IP in men were found for agricultural work, pesticide exposure, male carpenters, and in female cleaners. In advanced PD there is a need for further therapeutic improvements, and electroconvulsive therapy (ECT) is one insufficiently explored and evaluated method. In study III ECT 16 non-depressed, nondemented PD patients with advanced disease were treated with ECT. In all patients an antiparkinsonian effect of ECT was seen, lasting between a few days and 18 months. Five patients, all with signs of blood brain barrier damage, developed transitory mental confusion after ECT. The results indicated that ECT could cause increased dopaminergic activity, which led us to study IV. Single photon emission computed tomography (SPECT) with the cocaine analogue [123I]-β-CIT was used in order to visualise dopaminergic neurones in the brain. Six patients with PD were examined before and after a series of ECT, and in three cases SPECT was also repeated after one year. The side-to-side difference in the radiotracer uptake was found to be significantly lower in striatum located contralaterally to the part of the body with most pronounced symptomatology. No significant change in uptake of [123I]-β-CIT was seen after ECT, although all patients improved and the most pronounced improvement was seen in patients with less advanced PD. Study V points at two new positive observations with maintenance ECT (MECT). i.e. repeated ECT treatment of PD. One patient had either severe mental side effects on higher L-dopa doses or intolerable parkinsonian symptoms on lower doses. MECT implied marked improvement in parkinsonian symptoms without mental side effects. Another PD patient, who also had a mental depression, showed slight improvement of motor symptoms on a series of ECT. When treated with MECT further antiparkinsonian effects were seen.
On the day of the public defence the status of the article IV was: Submitted; articel V was: Accepted for publication after revision.
Estilos ABNT, Harvard, Vancouver, APA, etc.
4

水野, 正明, 純. 吉田, Masaaki Masaaki Mizuno e Jun Yoshida. "悪性グリオーマに対する遺伝子治療". 日本脳神経外科コングレス, 2006. http://hdl.handle.net/2237/10865.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
5

Gonzalez, Gomez Mayte Lorena. "Methylglyoxal Effects in Cell Therapy for Myocardial Infarction". Thesis, Université d'Ottawa / University of Ottawa, 2018. http://hdl.handle.net/10393/38431.

Texto completo da fonte
Resumo:
Methylglyoxal (MG), a highly reactive dicarbonyl accumulates after myocardial infarction (MI), causing adverse remodelling and cardiac dysfunction. We hypothesized that therapy using bone marrow cells (BMCs) overexpressing glyoxalase1 (Glo1), the main enzyme that metabolizes MG, injected into mouse MI model would translate into better survival of transplanted cells and improve their therapeutic effect. We found that Glo1 expression is significantly reduced at 7 days post-MI. Glo1 BMCs exposed to MG in vitro displayed greater angiogenic potential and reduced reactive oxygen species production compared to wild type (WT) BMCs. However, in the mouse MI model, Glo1 BMCs did not improve cardiac function or vascularity or reduce scar formation compared to WT BMCs and saline treatments. In conclusion, Glo1 overexpression in BMCs does not confer superior therapeutic efficacy for treating MI under the conditions tested.
Estilos ABNT, Harvard, Vancouver, APA, etc.
6

Balbadhur, Raksha. "Understanding the dignity experience and exploring the impact of dignity therapy and guided imagery on patients with advanced disease - a South African perspective". Master's thesis, University of Cape Town, 2017. http://hdl.handle.net/11427/24874.

Texto completo da fonte
Resumo:
Objectives: This study was conducted to understand the dignity experience of patients with advanced disease from diverse socio-economic and cultural backgrounds in a South African context. In addition, the psychotherapeutic interventions, Dignity Therapy and Guided Imagery (focused on intrinsic dignity), were implemented to enhance the dignity experience of these patients and its impact explored. Method: This was a qualitative study where a semi-structured interview guide was used in the exploration of the understanding of the dignity experience of patients with advanced diseases, receiving home care from two hospices in the North of Durban, KwaZulu-Natal. Interviews were audiotaped and transcribed verbatim. Data was analysed using thematic analysis. Dignity Therapy and Guided Imagery were subsequently implemented with these patients. Dignity therapy is an appreciative enquiry into the lives of patients to allow them to discuss aspects of their life that matter most, and the legacy and words of advice they would want most remembered. The sessions are audiotaped, transcribed and edited to produce a legacy document that can be given to their family or loved ones, if they so wish. Guided Imagery was implemented to affirm a practical experience of patients' intrinsic dignity and worth as beings. A post intervention patient feedback questionnaire, which involved a quantitative and qualitative component, was used to explore the impact of these interventions on different aspects of psychosocial and existential distress. The qualitative feedback was analysed using content analysis to determine the themes and sub-themes of benefit derived from the bundled interventions. Results: Four major themes defined the dignity experience: physical concerns, psychological concerns and coping mechanisms, social concerns and spiritual concerns and coping mechanisms. These themes and the numerous sub-themes provide an understanding of the total dignity experience of South African patients living with advanced disease. This study provided quantitative and qualitative data illustrating the impact of Dignity Therapy and Guided imagery, which proved to enhance the dignity experience of patients with advanced disease. The beneficial impact of Dignity Therapy and Guided Imagery on the dignity experience of dying patients was documented with confirmations on measures of helpfulness (100%), satisfaction (100%), a heightened sense of dignity (75%), purpose (100%) and meaning in life (92%). Further endorsements were expressed in terms of 83% sharing that it had lessened their sense of suffering, and feelings of anxiety and depression (92%) and improved their will to live (83%). The participants also expressed that the beneficial impact of interventions would spread beyond themselves to help their families (92%) and to benefit their relationship with their healthcare providers (92%). The interventions were shown qualitatively to have a beneficial impact on the Physical, Psychological, Social and Spiritual Domains of the participants' lives and these emerged as the four themes with various sub-themes. Conclusion: With this awareness of the biopsychosocial and existential concerns and psycho-existential coping mechanisms that affect the total dignity experience, healthcare providers can optimise dignity conserving care to improve the quality of lives of patients living with advanced disease. In this small study, Dignity Therapy and Guided Imagery are shown to be relevant, feasible and acceptable, short psychotherapeutic interventions that can be conducted at the bedside by healthcare providers to enhance the dignity experience of patients. A Guided Imagery focused on intrinsic dignity is shown to be a novel beneficial 5-minute intervention that can augment Dignity Therapy, or be used on its own, to affirm and strengthen the experience of the intrinsic worth of patients with advanced disease. Healthcare professionals have an influence in the area of the extrinsic sources of dignity in advanced disease, and can enhance dignity in providing respectful compassionate care. To add to the knowledge on dignity research, this study specifically highlights the need to affirm intrinsic dignity in dying patients, to affirm their personal worth.
Estilos ABNT, Harvard, Vancouver, APA, etc.
7

Hasfal, Sharon hasfal. "Development of a Scholarly Educational Intervention to Improve Inpatient Diabetes Care". ScholarWorks, 2018. https://scholarworks.waldenu.edu/dissertations/5086.

Texto completo da fonte
Resumo:
Advanced practice providers (APPs), consisting of nurse practitioners and physician assistants, face many challenges in the provision of evidence-based practice in their management of hospitalized adult patients with diabetes. Some of the barriers faced by APPs at a Northeast acute care facility are poor communication between disciplines, lack of confidence in initiating insulin, limited understanding of the management of insulin and the insulin pump, and insufficient treatment of the hospitalized patient with diabetes that aligns with current clinical guidelines for the management of inpatient hyperglycemia. This quality improvement project focused on the development of an evidence-based theory supported educational intervention to improve APPs' knowledge regarding glycemic management. An interdisciplinary team created the educational intervention using the analyze, design, develop, implement, and evaluate (ADDIE) instructional model. A 10-member expert panel validated the program utilizing both a formative and summative evaluation. The results from the formative evaluation was discussed with the interdisciplinary team, corrections were made, and was returned to the expert panel. Once the changes were made to the satisfaction of the expert panel, the program was then validated and submitted to the institution as a completed project to be used by the institution for APPs. This project addresses social change by increasing awareness in the management of inpatients with diabetes therefore decreasing fragmented care delivered by the APPs which will improve quality of care and patient safety.
Estilos ABNT, Harvard, Vancouver, APA, etc.
8

Fornaguera, Puigvert Cristina. "Development of multifunctional polymeric nanoparticles by nano-emulsion templating as advanced nanocarriers targeting the blood-brain barrier". Doctoral thesis, Universitat de Barcelona, 2015. http://hdl.handle.net/10803/285368.

Texto completo da fonte
Resumo:
Multifunctional polymeric nanoparticles (NP) represent a promising alternative for the treatment of neurodegenerative diseases using the intravenous route (i.v.). In current treatments, the effects of the intravenously injected drugs are systemic, requiring high drug doses to achieve therapeutic effects, thus causing severe side effects. NP can act specifically in a tissue provided that they are properly designed. An interesting approach is the preparation of NPs by nano-emulsion templating. Nano-emulsions (NE) are fine emulsions, with droplet sizes typically between 20 – 200nm. They can be prepared by the phase inversion composition (PIC) method, a low-energy emulsification method appropriate for pharmaceutical applications, since it can be performed at mild process conditions. Nanoparticles are obtained from nano-emulsions by solvent evaporation. To target the central nervous system (CNS), a specific targeting moiety on the nanoparticle surface is required to cross the blood-brain barrier (BBB), which is a current key goal under intense investigations. The aim of this work was to obtain multifunctional polymeric NP as advanced delivery systems able to cross the BBB. O/W polymeric NE were prepared by the PIC method and polymeric NPs were obtained by solvent evaporation. Polymeric NP with appropriate sizes for the i.v. administration (<1milimicron) were obtained. With the aim to design imaging systems, a model fluorescent dye and magnetic nanoparticles were encapsulated in polymeric NPs. An analgesic and an antiapoptotic drugs were also encapsulated into PLGA NP for therapeutic purposes. High encapsulation efficiencies were found for all tested compounds, attributed to the method of nanoparticle preparation as well as to low solubility of the components in the aqueous dispersion media. In addition, a sustained and controlled release of fluorescent dyes / drugs was achieved. NP surface was functionalized using various elements. On the one hand, it was functionalized with a monoclonal antibody against the transferring receptor, overexpressed in the BBB, to achieve an active targeting to the BBB. On the other hand, NPs were functionalized with oligonucleotides, to be used as non-viral gene delivery systems. Firstly, carbosilane cationic dendrons were covalently attached to nanoparticle surface to achieve a cationic surface. In a further step, antisense oligonucleotides, siRNA and plasmids were electrostatically bound to cationized nanoparticles. In vitro tests showed that the formulated NP did produce neither cytoxicity nor hemolysis. In addition, they were weak activators of the immune system and produced only a slight adsorption of blood proteins. Therefore, they are appropriate to be used by the i.v. route. NPs functionalized with oligonucleotides enhanced gene transfection in cell cultures, up to values comparable to those of commercial values (up to 90%). These NPs are advantageous in terms of toxicity issues over the commercial formulations. Therefore, they represent promising non-viral gene delivery systems. In vivo tests, which measured the central analgesia produced by an encapsulated drug into nanoparticles (loperamide) that is not able to cross the BBB, confirmed a central analgesic effect, reaching a potency of analgesia comparable to positive controls when nanoparticles were functionalized with the antibody. Therefore, the antibody functionalized nanoparticles efficiently crossed the BBB. In conclusion, the designed polymeric nanoparticles, functionalized with the antitransferrin receptor antibody, are able to cross the BBB with high efficiency. These nanoparticles represent promising nanosystems to deliver actives to the central nervous system.
Les nanopartícules polimèriques multifuncionals (NPs) representen una alternativa prometedora pel tractament de malalties neurodegeneratives, a través de l’administració intravenosa (i.v.), ja que els tractaments actuals provoquen molts efectes secundaris. Les NPs, en canvi, si estan correctament dissenyades, poden actuar específicament en el teixit diana. Ja que l’òrgan diana és el cervell, és necessari un element de vectorització per poder creuar la barrera hemato-encefàlica (BBB). En aquest context, l’objectiu de la present tesi és l’obtenció de NPs com a sistemes avançats d’alliberament de principis actius que travessin la BBB. Es van obtenir NPs a partir de nano-emulsions (NE) plantilla, emprant l’àcid poli-(làctic-co-glicòlic) com a polímer i el mètode d’inversió de fases a temperatura constant per emulsionar, seguit d’evaporació de solvent per obtenir NPs. Les NPs obtingudes tenen mides apropiades per l’administració i.v.. Es va aconseguir encapsular un fluorescent i NPs magnètiques dins les NPs polimèriques, per fer-les servir com a sistemes d’imatge. També es van encapsular fàrmacs per usar-les com a sistemes terapèutics. En tots els casos, es van aconseguir eficiències d’encapsulació molt elevades i un alliberament del fàrmac controlat i prolongat en el temps. A més, es va aconseguir funcionalitzar la superfície de les NPs amb diferents elements. Es van unir covalentment dendrons catiònics per posteriorment unir oligonucleòtids electrostàticament. També es va afegir una coberta exterior de polietilenglicol per protegir el material genètic. Per altra banda, es va funcionalitzar la superfície de les NPs amb un anticòs específic contra el receptor de la transferrina, sobreexpressat a la BBB. A continuació, es van fer assajos in vitro, que van posar de manifest que les NPs no són citotòxiques ni hemolítiques. També es va estudiar l’eficiència de transfecció cel•lular del material genètic, arribant a eficiències de transfecció equivalents a les dels vectors comercials. Assajos in vivo van permetre confirmar el pas a través de la BBB, sobretot de les NPs funcionalitzades amb l’anticòs. Els resultats obtinguts permeten concloure que s’ha aconseguit dissenyar noves NPs polimèriques a partir de NE, apropiades per l’administració i.v. i amb capacitat de travessar la BBB.
Estilos ABNT, Harvard, Vancouver, APA, etc.
9

Daum, Ruben [Verfasser]. "Development and Non-invasive Quality Assessment of Advanced Therapy Medicinal Products / Ruben Daum". Tübingen : Universitätsbibliothek Tübingen, 2021. http://d-nb.info/1232725773/34.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
10

Abou, El-Enein Mohamed [Verfasser]. "The economics of manufacturing clinical-grade advanced therapy medicinal products (ATMPs) / Mohamed Abou El-Enein". Berlin : Medizinische Fakultät Charité - Universitätsmedizin Berlin, 2014. http://d-nb.info/1046832859/34.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
Mais fontes

Livros sobre o assunto "Advanced therapy medicine"

1

Crane, D. Russell, Tai Mendenhall, Angela Lamson e Jennifer Hodgson. Medical family therapy: Advanced applications. Cham: Springer, 2014.

Encontre o texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
2

Utah College of Massage Therapy. Advanced eastern paradigm: Assessment & therapy. Salt Lake City, Utah: Utah College of Massage Therapy, 2003.

Encontre o texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
3

I, Resnick Martin, e Thompson Ian M. 1954-, eds. Advanced therapy of prostate disease. Hamilton, Ont: B.C. Decker, 2000.

Encontre o texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
4

1948-, Purdy R. Allan, ed. Advanced therapy of headache. 2a ed. Hamilton: BC Decker, 2005.

Encontre o texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
5

Chow, Kam Thye. Advanced Thai yoga massage: Postures and energy pathways for healing. Rochester, Vt: Healing Arts Press, 2011.

Encontre o texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
6

E, Molinari, Riva G e Wiederhold B. K, eds. Virtual environments in clinical psychology and neuroscience: Methods and techniques in advanced patient-therapist interaction. Amsterdam: IOS Press, 1998.

Encontre o texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
7

Hughes, Martin. Advanced Respiratory Critical Care. Oxford: Oxford University Press, 2011.

Encontre o texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
8

Samuels, Martin. Advanced paediatric life support: The practical approach. 5a ed. Chichester, West Sussex, UK: Wiley-Blackwell, 2012.

Encontre o texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
9

Aigner, Karl Reinhard. Induction Chemotherapy: Integrated Treatment Programs for Locally Advanced Cancers. Berlin, Heidelberg: Springer-Verlag Berlin Heidelberg, 2011.

Encontre o texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
10

Persing, Gary. Respiratory care exam review: Review for the entry level and advanced exams. 3a ed. Maryland Heights, Mo: Saunders Elsevier, 2010.

Encontre o texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
Mais fontes

Capítulos de livros sobre o assunto "Advanced therapy medicine"

1

Ventura, Jordi, e Xavier Santamaria. "Advanced Cell Therapy for Asherman's Syndrome". In Handbook of Genetic Diagnostic Technologies in Reproductive Medicine, 267–75. 2a ed. Boca Raton: CRC Press, 2022. http://dx.doi.org/10.1201/9781003024941-24.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
2

Díaz-Jimenez, Jose Pablo, e Rachid Tazi Mezalek. "Photodynamic Therapy for Early and Advanced Lung Cancer". In Interventions in Pulmonary Medicine, 147–63. New York, NY: Springer New York, 2012. http://dx.doi.org/10.1007/978-1-4614-6009-1_10.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
3

Junior, João Batista Silva, Renata Miranda Parca e Adriana Bastos Carvalho. "Advanced Therapy Products in Brazil: Regulatory Aspects". In Advances in Experimental Medicine and Biology, 117–33. Cham: Springer International Publishing, 2023. http://dx.doi.org/10.1007/978-3-031-34567-8_7.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
4

Shukla, S. K., C. Cipriani, G. Argirò, G. Atzei, F. Boccardi, S. Boemi, R. Cusumano e L. Ossicini. "Advanced Prostate Cancer Therapy with Yttrium-90 Citrate". In Radioactive Isotopes in Clinical Medicine and Research, 301–6. Basel: Birkhäuser Basel, 1997. http://dx.doi.org/10.1007/978-3-0348-7772-5_45.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
5

Boonprasirt, Piyanan, Sarun Nimvorapun, Chonticha Sawangjang, Sitanun Poonpolsub, Worasuda Yoongthong e Paisarn Dunkum. "Regulatory Frameworks for Advanced Therapy Medicinal Products in Thailand". In Advances in Experimental Medicine and Biology, 221–33. Cham: Springer International Publishing, 2023. http://dx.doi.org/10.1007/978-3-031-34567-8_13.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
6

Schuessler-Lenz, Martina, Carla Herberts, Ilona Reischl, Sol Ruiz, Patrick Celis, Claire Beuneu, Rune Kjeken e Marcos Timón. "Marketing Regulatory Oversight of Advanced Therapy Medicinal Products in Europe". In Advances in Experimental Medicine and Biology, 1–21. Cham: Springer International Publishing, 2023. http://dx.doi.org/10.1007/978-3-031-34567-8_1.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
7

Mirjanić, D. Lj, e S. Pelemiš. "Intelligent Nanomaterials for Medicine Diagnostic and Therapy Application". In Proceedings of the IV Advanced Ceramics and Applications Conference, 121–28. Paris: Atlantis Press, 2017. http://dx.doi.org/10.2991/978-94-6239-213-7_10.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
8

Lapa, Constantin, K. Martin Kortüm e Ken Herrmann. "CXCR4-Directed Endoradiotherapy as New Treatment Option in Advanced Multiple Myeloma". In Clinical Applications of Nuclear Medicine Targeted Therapy, 475–81. Cham: Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-63067-0_36.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
9

Renner, Matthias, Brigitte Anliker, Ralf Sanzenbacher e Silke Schuele. "Regulation of Clinical Trials with Advanced Therapy Medicinal Products in Germany". In Advances in Experimental Medicine and Biology, 87–101. Cham: Springer International Publishing, 2015. http://dx.doi.org/10.1007/978-3-319-18618-4_5.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
10

de Freitas, Daniel Roberto Coradi. "The Regulatory Pathway for Advanced Cell Therapy and Gene Therapy Products in Brazil: A Road to Be Built". In Advances in Experimental Medicine and Biology, 213–19. Cham: Springer International Publishing, 2015. http://dx.doi.org/10.1007/978-3-319-18618-4_12.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.

Trabalhos de conferências sobre o assunto "Advanced therapy medicine"

1

Wang, Lian-xing, Lu-pin Dai e Wen-qin Lu. "Photodynamic therapy of advanced malignant tumors". In International Conference on Photodynamic Therapy and Laser Medicine, editado por Junheng Li. SPIE, 1993. http://dx.doi.org/10.1117/12.137013.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
2

Nadauld, Lincoln D., Burke Van Norman, Gail Fulde, David newman, Allison Butler, Brian Tudor, Heather Gilbert et al. "Abstract PR07: Precision genomic medicine improves clinical outcomes in advanced cancer patients". In Abstracts: AACR Precision Medicine Series: Integrating Clinical Genomics and Cancer Therapy; June 13-16, 2015; Salt Lake City, UT. American Association for Cancer Research, 2016. http://dx.doi.org/10.1158/1557-3265.pmsclingen15-pr07.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
3

Shosha, Mohammed. "Qigong Therapy and Low Back Pain Syndrome in Adults a Narrative Review". In 2nd International Conference on Advanced Research in Education. Acavent, 2019. http://dx.doi.org/10.33422/2nd.educationconf.2019.11.803.

Texto completo da fonte
Resumo:
Low back pain (LBP) is a common disorder bothering many people in daily life. Qigong as a part of traditional Chinese medicine (TCM), is considered to be an effective therapy method in promoting health and reduce back pain in adults. Purpose: The purpose of the present study was to review and analyze the existing data about Qigong exercise and its possible effects as alternative medicine on pain and back problems in individuals with low back pain. Methods: Potentially related articles were narratively retrieved from the electronic databases PubMed and Physiotherapy Evidence Database (PEDRO). The search period was from January 2015 to August 2019 (01.01.2015 to 31.08.2019) and the keywords included the terms “Low back pain “and “Qigong”. Results: The main results of this study suggest the potential use of Qigong as a meditative easy movement may improve back function, range of motion and core muscle strength, it may also reduce the pain intensity and considered as a good strategy for pain management. This review might lend insight into more future studies on Qigong and its application in the treatment and prevention of low back pain. However, further experimental research is still needed.
Estilos ABNT, Harvard, Vancouver, APA, etc.
4

Chantrill, Lorraine, Skye Simpson, Amber Johns, Mona Martyn-Smith, Angela Chou, Clare Watson, Adnan Nagrial et al. "Abstract CT210: Precision medicine for advanced pancreas cancer: the individualized molecular pancreatic cancer therapy (IMPaCT) trial". In Proceedings: AACR 106th Annual Meeting 2015; April 18-22, 2015; Philadelphia, PA. American Association for Cancer Research, 2015. http://dx.doi.org/10.1158/1538-7445.am2015-ct210.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
5

Chernavski, D. S., V. P. Karp, Alexander P. Nikitin, I. V. Rodshtad e Boris V. Zubov. "Autodiagnostic system and puncture therapy". In Selected Papers from Seventh Internation Conference on Advanced Laser Technologies (ALT'98): Laser Methods in Medicine and Biology, editado por Alexander M. Prokhorov, Vladimir I. Pustovoy e Genadi P. Kuz'min. SPIE, 1999. http://dx.doi.org/10.1117/12.353120.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
6

Pankov, O. P. "Low-level therapy in ophthalmology". In Selected Papers from Seventh Internation Conference on Advanced Laser Technologies (ALT'98): Laser Methods in Medicine and Biology, editado por Alexander M. Prokhorov, Vladimir I. Pustovoy e Genadi P. Kuz'min. SPIE, 1999. http://dx.doi.org/10.1117/12.353124.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
7

"DESIGN OF PRODUCTS AND SERVICES FOR THE AUTOMATION OF CELL CULTURE IN THE PRODUCTION OF ADVANCED THERAPY MEDICINE". In 16th International Conference on Computer Graphics, Visualization, Computer Vision and Image Processing (CGVCVIP 2022), the 8th International Conference on Connected Smart Cities (CSC 2022), 7th International Conference on Big Data Analytics, Data Mining and Computational Intelligence (BigDaCI’22) and 11th International Conference on Theory and Practice in Modern Computing (TPMC 2022). IADIS Press, 2022. http://dx.doi.org/10.33965/mccsis2022_202206l024.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
8

Bidaut, Luc. "Multimodality and Advanced Biomedical Imaging for Clinical and Research Applications". In ASME 2010 First Global Congress on NanoEngineering for Medicine and Biology. ASMEDC, 2010. http://dx.doi.org/10.1115/nemb2010-13314.

Texto completo da fonte
Resumo:
Driven in particular by the availability of ever more refined imaging modalities — such as faster and higher resolution CT and MR, or hybrid PET/CT and SPECT/CT — and by a marked increase in computing power, advanced biomedical imaging — e.g. through its multidimensional and multimodal paradigms — is taking an ever bigger place in both research and clinical routine, and for both diagnostic applications and therapy management. While human modalities are widely publicized, there is a similar plethora of imaging systems for small animals, which permits relatively fast translation of successful image-based protocols from research evaluation to the clinic. Because of their characteristics and the need for more detailed information about normal vs. diseased tissues, modern modalities produce huge amounts of information and images. The only way to digest these is through advanced paradigms that combine or reduce the complexity of the information so that it can be interpreted by normal human beings. This presentation will introduce techniques and research or clinical applications of advanced imaging for both animals and humans.
Estilos ABNT, Harvard, Vancouver, APA, etc.
9

Aizawa, Yasunori. "1228-A Enhancing cell therapy & regenerative medicine: advanced iPSC genome engineering via Logomix Genome-WritingTMplatform". In SITC 38th Annual Meeting (SITC 2023) Abstracts Supplement 2. BMJ Publishing Group Ltd, 2023. http://dx.doi.org/10.1136/jitc-2023-sitc2023.1228-a.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
10

Wallis, R. S., S. Ginindza, T. Beattie, N. Arjun, M. Likoti, V. Edward, M. Rassool et al. "Preliminary Results of an Experimental Medicine Trial of Adjunctive Host-Directed Therapy in Adults with Moderately or Far-Advanced Rifampin-Susceptible Pulmonary Tuberculosis". In American Thoracic Society 2019 International Conference, May 17-22, 2019 - Dallas, TX. American Thoracic Society, 2019. http://dx.doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a7388.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.

Relatórios de organizações sobre o assunto "Advanced therapy medicine"

1

Zhao, Hui Yan, Sungha Kim, ChangSop Yang e Mi Ju Son. Comparing acupoint catgut embedding and acupuncture therapies in simple obesity: Protocol for a systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, outubro de 2021. http://dx.doi.org/10.37766/inplasy2021.10.0014.

Texto completo da fonte
Resumo:
Review question / Objective: How effective are acupoint catgut embedding therapy sole or with other treatment? Condition being studied: Simple obesity. Information sources: We will search for trials from the following electronic databases: MEDLINE, EMBASE, the Cochrane Central Register of Controlled Trials (CENTRAL), and the Cumulative index to Nursing and Allied Health Literature (CINAHL). Trials will also be searched from three Korean medical databases (Oriental Medicine Advanced Searching Integrated System [OASIS], Science-On and KoreaMed), a Chinese database (Chinese National Knowledge Infrastructure [CNKI]) and a Japanese database (CiNii). Ongoing trials, trials will be searched on the Clinical Trials. gov (http://www.ClinicalTrials.gov), and the WHO International Clinical Trials Registry Platform (ICTRP) (http://apps.who.int/trialsearch/). We will also check the reference lists of reviews and the retrieved articles for additional studies. All bibliographic information and articles will be managed using EndNote (X8.2; Clarivate Analytics, Philadelphia). If the data of study are missing or insufficient, we will contact the corresponding authors by email.
Estilos ABNT, Harvard, Vancouver, APA, etc.
2

Zhao, Hui Yan, Sungha Kim, ChangSop Yang e Mi Ju Son. Comparing acupoint catgut embedding and acupuncture therapies in simple obesity: Protocol for a systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, outubro de 2021. http://dx.doi.org/10.37766/inplasy2021.10.0014.

Texto completo da fonte
Resumo:
Review question / Objective: How effective are acupoint catgut embedding therapy sole or with other treatment? Condition being studied: Simple obesity. Information sources: We will search for trials from the following electronic databases: MEDLINE, EMBASE, the Cochrane Central Register of Controlled Trials (CENTRAL), and the Cumulative index to Nursing and Allied Health Literature (CINAHL). Trials will also be searched from three Korean medical databases (Oriental Medicine Advanced Searching Integrated System [OASIS], Science-On and KoreaMed), a Chinese database (Chinese National Knowledge Infrastructure [CNKI]) and a Japanese database (CiNii). Ongoing trials, trials will be searched on the Clinical Trials. gov (http://www.ClinicalTrials.gov), and the WHO International Clinical Trials Registry Platform (ICTRP) (http://apps.who.int/trialsearch/). We will also check the reference lists of reviews and the retrieved articles for additional studies. All bibliographic information and articles will be managed using EndNote (X8.2; Clarivate Analytics, Philadelphia). If the data of study are missing or insufficient, we will contact the corresponding authors by email.
Estilos ABNT, Harvard, Vancouver, APA, etc.
Você também pode estar interessado nas extensas listas de trabalhos sobre o assunto "Advanced therapy medicine":
Artigos de revistas Teses / dissertações Livros
Oferecemos descontos em todos os planos premium para autores cujas obras estão incluídas em seleções literárias temáticas. Contate-nos para obter um código promocional único!

Vá para a bibliografia